Initiation of metformin in MELAS patient-a dangerous combination

Clin Toxicol (Phila). 2022 Mar;60(3):412-413. doi: 10.1080/15563650.2021.1966029. Epub 2021 Aug 17.

Authors

Joshua Trebach^{1

2}, Danish Ghazali³, Devin J Burke³, Sarah G Mahonski^{1

2}, Robert S Hoffman^{1

2}

Affiliations

¹ Ronald O. Perelman Department of Emergency Medicine, Division of Medical Toxicology, NYU Grossman School of Medicine, New York, NY, USA.
² Department of Health and Mental Hygiene, New York City Poison Control Center, New York, NY, USA.
³ Department of Neurology, Columbia University Medical Center, New York, NY, USA.

PMID: 34402712
DOI: 10.1080/15563650.2021.1966029

No abstract available

Publication types

Letter

MeSH terms

Cognition
Diabetes Mellitus, Type 2*
Humans
MELAS Syndrome* / drug therapy
Metformin* / therapeutic use

Substances

Metformin